Clinical Trial Update: Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

View source ↗

Summary

The trial examining biopsy specimens to study responses to PD-1 or PD-L1 therapies has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non Small Cell Lung Cancer | Status: WITHDRAWN